The Impacts of Synthetic Chemistry on Human Health

[1]  Vladimir Poroikov,et al.  Multi-targeted natural products evaluation based on biological activity prediction with PASS. , 2010, Current pharmaceutical design.

[2]  P. Arya,et al.  Exploring new chemical space by stereocontrolled diversity-oriented synthesis. , 2005, Chemistry & biology.

[3]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[4]  David J. Stevens,et al.  The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design , 2006, Nature.

[5]  G. Schneider,et al.  The State of the Art of Chemical Biology , 2009, Chembiochem : a European journal of chemical biology.

[6]  D. Isaacs,et al.  Carbohydrate-protein conjugate vaccines. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  Andrew Simon Bell,et al.  Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction , 1996 .

[8]  Stuart L Schreiber,et al.  Towards the optimal screening collection: a synthesis strategy. , 2008, Angewandte Chemie.

[9]  M. von Itzstein,et al.  Recent strategies in the search for new anti-influenza therapies. , 2003, Current drug targets.

[10]  Günther Wess,et al.  Medicinal Chemistry: Challenges and Opportunities. , 2001, Angewandte Chemie.

[11]  S. Szu,et al.  Bacterial polysaccharide–protein conjugate vaccines , 1999 .

[12]  Chi‐Huey Wong,et al.  Carbohydrate-Based Antibiotics: A New Approach to Tackling the Problem of Resistance. , 2001, Angewandte Chemie.

[13]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[14]  R. Roy,et al.  Antigenicity and Immunogenicity of a Synthetic Oligosaccharide-Protein Conjugate Vaccine against Haemophilus influenzae Type b , 2004, Infection and Immunity.

[15]  Herbert Waldmann,et al.  Synthesis of natural product inspired compound collections. , 2009, Angewandte Chemie.

[16]  Stuart L Schreiber,et al.  A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.

[17]  Mark von Itzstein,et al.  The war against influenza: discovery and development of sialidase inhibitors , 2007, Nature Reviews Drug Discovery.

[18]  M. Moreau,et al.  Polysaccharide Based Vaccines for The Prevention of Pneumococcal Infections , 2000 .

[19]  R. Roy,et al.  A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b , 2004, Science.

[20]  R. Roy.  New trends in carbohydrate-based vaccines. , 2004, Drug discovery today. Technologies.

[21]  P. Arya,et al.  Advances in solution- and solid-phase synthesis toward the generation of natural product-like libraries. , 2009, Chemical reviews.

[22]  C. Walsh,et al.  Introduction: antibiotic resistance. , 2005, Chemical Reviews.

[23]  V. Pozsgay.  Oligosaccharide-protein conjugates as vaccine candidates against bacteria. , 2000, Advances in carbohydrate chemistry and biochemistry.

[24]  Nicholas A. McGrath,et al.  A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives , 2010 .

[25]  David R Spring,et al.  Chemical genetics to chemical genomics: small molecules offer big insights. , 2005, Chemical Society reviews.

[26]  Chunhai Fan,et al.  Inside Cover: Ultrastable, Highly Fluorescent, and Water‐Dispersed Silicon‐Based Nanospheres as Cellular Probes (Angew. Chem. Int. Ed. 1/2009) , 2009 .